Use of modafinil to moderate the relationship between cancer-related fatigue and depression in 541 patients receiving chemotherapy: A URCC CCOP study.
Claire C. Conley(Georgetown University), Oxana Palesh(Virginia Commonwealth University), Howard M. Gross(Dayton Clinical Oncology Program), Luke J. Peppone(University of Rochester Medical Center), Charles Kamen(University of Rochester), Karen M. Mustian(University of Rochester Medical Center), Charles E. Heckler(University of Rochester Medicine), Gary R. Morrow(University of Rochester Medical Center), Shaker R. Dakhil(Cancer Center of Kansas), Michelle C. Janelsins(University of Rochester), Anthony J. Scalzo(Hematology Oncology Associates of Central New York)
Cited by 0
Related Papers
Cancer-Related Fatigue, Version 2.2015
|Journal of the National Comprehensive Cancer Network|2015|951
Comparison of Pharmaceutical, Psychological, and Exercise Treatments for Cancer-Related Fatigue
|JAMA Oncology|2017|913
Recommendations for the Use of Antiemetics: Evidence-Based, Clinical Practice Guidelines
|Journal of Clinical Oncology|1999|670